Back to Search
Start Over
Induction of liver-resident memory T cells and protection at liver-stage malaria by mRNA-containing lipid nanoparticles.
- Source :
-
Frontiers in immunology [Front Immunol] 2023 Aug 23; Vol. 14, pp. 1116299. Date of Electronic Publication: 2023 Aug 23 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Recent studies have suggested that CD8 <superscript>+</superscript> liver-resident memory T (T <subscript>RM</subscript> ) cells are crucial in the protection against liver-stage malaria. We used liver-directed mRNA-containing lipid nanoparticles (mRNA-LNPs) to induce liver T <subscript>RM</subscript> cells in a murine model. Single-dose intravenous injections of ovalbumin mRNA-LNPs effectively induced antigen-specific cytotoxic T lymphocytes in a dose-dependent manner in the liver on day 7. T <subscript>RM</subscript> cells (CD8 <superscript>+</superscript> CD44 <superscript>hi</superscript> CD62L <superscript>lo</superscript> CD69 <superscript>+</superscript> KLRG1 <superscript>-</superscript> ) were induced 5 weeks after immunization. To examine the protective efficacy, mice were intramuscularly immunized with two doses of circumsporozoite protein mRNA-LNPs at 3-week intervals and challenged with sporozoites of Plasmodium berghei ANKA. Sterile immunity was observed in some of the mice, and the other mice showed a delay in blood-stage development when compared with the control mice. mRNA-LNPs therefore induce memory CD8 <superscript>+</superscript> T cells that can protect against sporozoites during liver-stage malaria and may provide a basis for vaccines against the disease.<br />Competing Interests: SaM is an employee of SHIONOGI & CO., LTD. This work was supported by SHIONOGI & CO., LTD. Osaka, Japan. Nagasaki University and SHIONOGI & CO., LTD. launched the Shionogi Global Infectious Division SHINE at the Institute of Tropical Medicine NEKKEN, Nagasaki University. Based on the contract for this collaboration, SHIONOGI & CO., LTD. provided funding and contributed to improving the work through frequent discussions with the authors. However, SHIONOGI & CO., LTD. had no role in the experiments, data analysis, writing, or reviewing the paper.<br /> (Copyright © 2023 Nakamae, Miyagawa, Ogawa, Kamiya, Taniguchi, Ono, Kawaguchi, Teklemichael, Jian, Araki, Katagami, Mukai, Annoura, Yui, Hirayama, Kawakami and Mizukami.)
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 14
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 37680630
- Full Text :
- https://doi.org/10.3389/fimmu.2023.1116299